Tag: Levitee Labs - Psychedelic Alpha

Read more about the article Levitee Labs Announces Philip Van Den Berg to Join as Interim CEO and the Board of Directors and Close First Tranche of Private Placement for $1.5 Million

Levitee Labs Announces Philip Van Den Berg to Join as Interim CEO and the Board of Directors and Close First Tranche of Private Placement for $1.5 Million

Post published:February 1, 2022
Post category:Press Release

Levitee Labs Announces Medical Advisory Board

Post published:January 6, 2022
Post category:Press Release

Read more about the article Levitee Labs Appoints Dr. Mohammed Mosli as Chief People Officer of Levitee Clinics and Pharmacies in Alberta, Canada

Levitee Labs Appoints Dr. Mohammed Mosli as Chief People Officer of Levitee Clinics and Pharmacies in Alberta, Canada

Post published:October 14, 2021
Post category:Press Release

Levitee Labs Announces DTC Eligibility Approval

Post published:September 24, 2021
Post category:Press Release

Levitee Labs Commences Trading in U.S. Under Ticker LVTTF

Post published:September 9, 2021
Post category:Press Release

Levitee Labs Appoints NIH Physician-Scientist Dr. Fady Hannah-Shmouni as Chief Medical and Scientific Officer

Post published:August 5, 2021
Post category:Press Release

Levitee Labs Acquires Five Addiction Clinics in Alberta

Post published:July 29, 2021
Post category:Press Release

Levitee Labs Acquires Three Specialized Alberta Pharmacies

Post published:July 29, 2021
Post category:Press Release

Levitee Labs Announces Completion of Acquisition of BlockMD Telemedicine Platform

Post published:July 28, 2021
Post category:Press Release

Levitee Labs Signs Definitive Agreements to Acquire Clinics, Pharmacies, and a Telemedicine Company in Alberta

Post published:July 23, 2021
Post category:Press Release

Weekly Bulletin

Your weekly recap of news and analysis from the psychedelic sector.

Research Review

A monthly review of the most important psychedelics research.

News & Interviews

The latest news from across the psychedelics space.

Psychedelics Patent Trackers

We track the latest patents and filings related to psilocybin, MDMA and DMT.

Psychedelic Legalization & Decriminalization Tracker

Mapping psychedelic drug policy reform across the United States

Psychedelics Drug Development Tracker

From drug discovery to regulatory approval, we map drug development in psychedelics.

Stocks & Companies Directory

A directory of all the major psychedelics stocks, companies and ETFs.

Sector Landscape Map

Explore the Psychedelic Sector Landscape visually using our new tool.

Stock Watchlist

A one-stop overview of psychedelics stocks financial performance.

Levitee Labs Announces Philip Van Den Berg to Join as Interim CEO and the Board of Directors and Close First Tranche of Private Placement for $1.5 Million

Levitee Labs Announces Medical Advisory Board

Levitee Labs Appoints Dr. Mohammed Mosli as Chief People Officer of Levitee Clinics and Pharmacies in Alberta, Canada

Levitee Labs Announces DTC Eligibility Approval

Levitee Labs Commences Trading in U.S. Under Ticker LVTTF

Levitee Labs Appoints NIH Physician-Scientist Dr. Fady Hannah-Shmouni as Chief Medical and Scientific Officer

Levitee Labs Acquires Five Addiction Clinics in Alberta

Levitee Labs Acquires Three Specialized Alberta Pharmacies

Levitee Labs Announces Completion of Acquisition of BlockMD Telemedicine Platform

Levitee Labs Signs Definitive Agreements to Acquire Clinics, Pharmacies, and a Telemedicine Company in Alberta

Psychedelic Alpha

Quick Links

Newsletter

Join Our Newsletter

Psychedelic sector insights, interviews and analysis delivered to your inbox.

No thanks, continue to site.